Astria Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
25.17
|
|
Average Rating
|
4.83
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.92
|
-0.87
|
0.05
|
5.43%
|
|
2022-06-30
|
-1.01
|
-0.86
|
0.15
|
14.85%
|
|
2022-03-31
|
-0.73
|
-1.18
|
-0.45
|
-61.64%
|
|
2021-12-31
|
-0.66
|
-11.00
|
-10.34
|
-1566.67%
|
|
2021-09-30
|
-0.77
|
-0.61
|
0.16
|
20.78%
|
|
2021-06-30
|
-1.82
|
-5.34
|
-3.52
|
-193.41%
|
|
2021-03-31
|
-0.92
|
-45.60
|
-44.68
|
-4856.52%
|
|
2020-12-31
|
-2.22
|
-2.64
|
-0.42
|
-18.92%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.91
|
|
2021-12-31
|
-62.55
|
|
2020-12-31
|
-12.18
|
|
2019-12-31
|
-7.90
|
|
2018-12-31
|
-6.90
|
|
2017-12-31
|
-12.80
|
|
2016-12-31
|
-6.46
|
|
2015-12-31
|
-9.25
|